Clinical Trials
3
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
A Study of Acthar Gel Alone or With Tacrolimus to Reduce Proteinuria in Fibrillary Glomerulopathy Patients
- Conditions
- Fibrillary Glomerulonephritis
- Interventions
- First Posted Date
- 2022-09-19
- Last Posted Date
- 2022-10-31
- Lead Sponsor
- NephroNet, Inc.
- Target Recruit Count
- 34
- Registration Number
- NCT05546047
- Locations
- 🇺🇸
Stanford University, Stanford, California, United States
🇺🇸University of Colorado Anschutz Medical Department of Medicine Division of Renal Diseases and Hypertension, Aurora, Colorado, United States
🇺🇸Georgia Nephrology DBA Georgia Nephrology Research Institute, Lawrenceville, Georgia, United States
A Prospective, Randomized, Open-Label, Cross-Over Study of Lokelma to Control Interdialytic Hyperkalemia
- First Posted Date
- 2022-09-10
- Last Posted Date
- 2024-06-05
- Lead Sponsor
- NephroNet, Inc.
- Target Recruit Count
- 88
- Registration Number
- NCT05535920
- Locations
- 🇺🇸
Balboa Research, La Jolla, California, United States
🇺🇸Georgia Nephrology DBA Georgia Nephrology Research Institute, Lawrenceville, Georgia, United States
🇺🇸Nephrology Associates of Northern Illinois and Indiana (NANI), Fort Wayne, Indiana, United States
Comparative and Efficacy Study of ACTHar Gel Alone or in Combination With Tacrolimus in Fibrillary Glomerulopathy
- Conditions
- Renal Disease
- Interventions
- First Posted Date
- 2019-09-06
- Last Posted Date
- 2022-09-22
- Lead Sponsor
- NephroNet, Inc.
- Registration Number
- NCT04080076
- Locations
- 🇺🇸
Georgia Nephrology Research Institute, Lawrenceville, Georgia, United States